From the Guidelines
The most common cause of nephrotic syndrome in children is Minimal Change Disease (MCD), accounting for more than 75% of all pediatric cases and for 90% of cases in children under 5 years of age. This condition is characterized by normal-appearing glomeruli under light microscopy but shows foot process effacement when examined with electron microscopy. MCD typically presents with sudden onset of proteinuria, hypoalbuminemia, edema, and hyperlipidemia - the classic tetrad of nephrotic syndrome.
Key Characteristics of MCD
- Normal-appearing glomeruli under light microscopy
- Foot process effacement under electron microscopy
- Sudden onset of proteinuria, hypoalbuminemia, edema, and hyperlipidemia The condition usually responds well to corticosteroid therapy, with most children achieving remission within 2-4 weeks of starting prednisone at a dose of 2 mg/kg/day (maximum 60 mg/day), as recommended by the KDIGO 2021 guideline for the management of glomerular diseases 1.
Treatment Approach
- Daily prednisone for 4-6 weeks followed by alternate-day therapy for another 4-6 weeks
- Total treatment duration of 8-12 weeks, as updated by the KDIGO 2021 guideline 1
- Consideration of glucocorticoid-sparing agents for frequently relapsing or glucocorticoid-dependent patients, such as levamisole or rituximab, as suggested by recent studies 1 The good response to steroids gives this condition its alternative name "steroid-sensitive nephrotic syndrome." The exact cause of MCD remains unclear, but it is believed to involve immune system dysfunction, particularly T-cell abnormalities that affect podocyte function and increase glomerular permeability to proteins, as discussed in the study by Kidney International in 2007 1.
Long-term Prognosis
- Excellent long-term prognosis for most children with MCD
- Approximately 60-80% may experience relapses requiring additional courses of steroid therapy
- Importance of genetic testing to clarify the use of immunosuppressive agents in steroid-resistant cases, as recommended by the KDIGO 2021 guideline 1
From the Research
Causes of Nephrotic Syndrome in Children
- The most common cause of nephrotic syndrome in children is minimal change nephrotic syndrome (MCNS), accounting for 90% of cases under the age of 10 years and more than 50% in older children 2.
- MCNS is characterized by a disorder of T-lymphocytes, which release a cytokine that injures the glomerular epithelial cells, leading to albuminuria 2.
- Other causes of nephrotic syndrome in children include focal segmental glomerulosclerosis (FSGS), which is usually resistant to corticosteroids and carries a significant risk of kidney failure 3.
Characteristics of Minimal Change Nephrotic Syndrome
- MCNS generally responds to corticosteroids, although most patients experience disease relapses 4, 3.
- The disease is characterized by a high rate of relapse, with 70% of children with MCNS having a steroid-dependent or frequent relapsing course of the disease 5.
- The presence of mesangial hypercellularity and glomerular hypertrophy in renal biopsies of patients with MCNS may indicate a higher risk for progressive renal disease 2.
Treatment and Prognosis
- Corticosteroids are considered first-line therapy for the treatment of nephrotic syndrome, with prednisone therapy initiated at doses of 60 mg/m2 per day 4.
- Alternative therapies, such as immunosuppressive medications, may be used to prevent relapses and treat corticosteroid-resistant disease 4, 3.
- The prognosis for children with MCNS is generally good, with most patients achieving remission, although some may require prolonged immunosuppressive treatment 5, 2.